Net shares · 30d
-679
0 buy · 679 sell
Net value · 30d
-$10.9K
$0 in · $10.9K out
Sentiment · 30d
Net selling
0% buying · 100% selling
Open-market trades · 30d
1
0 buy · 679 sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 30d
-
CGEM Grant·A
Director
$0
21.8K sh
Own New
-
AVTX Other·F
Chief Medical Officer
$14.2K
1.1K sh · $13.10
Own -2%
-
AVTX Exercise·M
Chief Medical Officer · 10b5-1
$0
679 sh
Own +1%
-
AVTX Sell·S
Chief Medical Officer · 10b5-1
$10.9K
679 sh · $16.00
Own -1%
-
AVTX Exercise·M
Chief Medical Officer · 10b5-1
$5.5K
679 sh · $8.04
Own +1%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | CGEM | Grant A | 21.8K | $0 |
| Jun 10, 2026 | AVTX | Other F | 1.1K | $14.2K |
| May 28, 2026 | AVTX | Exercise M | 679 | $0 |
| May 28, 2026 | AVTX | Sell S | 679 | $10.9K |
| May 28, 2026 | AVTX | Exercise M | 679 | $5.5K |
Buy Sell Non-market (grant · exercise · gift)
About Doyle Mittie
This profile aggregates every SEC Form 4 insider transaction reported by Doyle Mittie across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.